2014

Manel Esteller, awarded the Prize of Honor Dr. Benaprès 2014

Leave a Comment / Uncategorised / By

The Director of Epigenetics and Cancer Biology Program at the Bellvitge Biomedical Research Institute (IDIBELL), ICREA Research and Professor at the University of Barcelona, ​​Manel Esteller, earned the Award of Honor Dr. Benaprès 2014 for his scientific career, awarded by the Spanish Society of Cosmetic Medicine and Surgery. The award is given for the multiple […]

Manel Esteller, awarded the Prize of Honor Dr. Benaprès 2014 Read More »

IDIBELL prepares the Human Resources Strategy for Researchers 2014-2017

Leave a Comment / HRS4R / By

The European Commission has adopted the “European Charter for Researchers” and the “Code of Conduct for the Recruitment of Researchers” as key elements to encourage the mobility of researchers and the harmonization of their work conditions across Europe. IDIBELL endorsed the principles outlined by these two documents on August 1st 2013. Some of the highlights

IDIBELL prepares the Human Resources Strategy for Researchers 2014-2017 Read More »

Students of the University of Leiden visit IDIBELL within their route around the research done Spain

Leave a Comment / Diabetes, Nutrition and endocrinological diseases  / By

On Monday April 28th, a group of medical students at the University of Leiden, The Netherlands, has known a little bit about the research conducted in the IDIBELL. This visit is part of the study tour that the association of students of the Faculty of Medicine, Leiden organizes every year for several research institutes from

Students of the University of Leiden visit IDIBELL within their route around the research done Spain Read More »

IDIBELL, University Hospital of Bellvitge and UPC collaborate to develop new health technologies

Leave a Comment / Innovation / By

IDIBELL, University Hospital of Bellvitge and the Polytechnic University of Catalonia (UPC) have signed a cooperation agreement in the field of education, research and innovation to share knowledge and needs that will allow the development of new health technologies. The agreement establishes a framework for relations between the three institutions for future collaboration in order

IDIBELL, University Hospital of Bellvitge and UPC collaborate to develop new health technologies Read More »

Jaume Reventós: “Together we can move forward”

Leave a Comment / Uncategorised / By

On Wednesday April 2, the auditorium of the University Hospital of Bellvitge hosted the presentation of the new IDIBELL general manager, Jaume Reventós. The event was attended by members of the delegate Commission of the institution Jordi Alberch , Vice Chancellor of the University of Barcelona ; Alfredo Garcia Director of the University Hospital of

Jaume Reventós: “Together we can move forward” Read More »

3D biotechnology, protagonist of the workshop of the European project IT-LIVER in Vienna

Leave a Comment / Innovation, TGF-beta and cancer / By

On February 27th and 28th the University of Vienna hosted the second workshop of the European project IT-Liver, funded by the Marie Curie ITN (Initial Training Network) program of the European Commission (FP7) and coordinated by the head of the Biological clues of the invasive and metastasic phenotype research group at IDIBELL, Isabel Fabregat. In

3D biotechnology, protagonist of the workshop of the European project IT-LIVER in Vienna Read More »

Discovery of a mechanism that makes tumor cells sugar addicted

Leave a Comment / Nutrition, metabolism and Gene Therapy , Psychoneurobiology of Eating and Addictive Behaviours / By

For almost a hundred years ago is known that cancer cells feel a special appetite for a type of sugar called glucose. The tumor uses this molecule is like the gasoline which depends a sports car to burn faster and grows and multiplies rapidly. It is a little cash process from the energy point of

Discovery of a mechanism that makes tumor cells sugar addicted Read More »

Scroll to Top